A new role for old ligands: discerning chelators for zinc metalloproteinases
- PMID: 16522091
- DOI: 10.1021/ja057957s
A new role for old ligands: discerning chelators for zinc metalloproteinases
Abstract
In an effort to identify promising non-hydroxamate inhibitors of matrix metalloproteinases (MMPs) several new zinc-binding groups (ZBGs) based on pyridine-derived or aza-macrocycle chelators have been examined. Fluorescence-based enzyme assays have been used to determine the IC50 values for these ZBGs against MMP-1, MMP-3, and anthrax lethal factor (LF). Many of these ligands were found to be remarkably potent, with IC50 values as much as 185-fold lower than that found for acetohydroxamic acid. These ligands are proposed to be more selective "warheads" for the inhibition of metalloenzymes that contain Zn2+ versus other metal ions at their active site.
Similar articles
-
New beginnings for matrix metalloproteinase inhibitors: identification of high-affinity zinc-binding groups.J Am Chem Soc. 2004 Jul 14;126(27):8388-9. doi: 10.1021/ja0485513. J Am Chem Soc. 2004. PMID: 15237990
-
Pyrimidine-2,4,6-Triones: a new effective and selective class of matrix metalloproteinase inhibitors.Biol Chem. 2001 Aug;382(8):1277-85. doi: 10.1515/BC.2001.159. Biol Chem. 2001. PMID: 11592410
-
Ternary ligand-zinc-hydroxamate complexes.Inorg Chem. 2005 Jan 10;44(1):40-4. doi: 10.1021/ic0493090. Inorg Chem. 2005. PMID: 15627358
-
The design of inhibitors for medicinally relevant metalloproteins.ChemMedChem. 2007 Feb;2(2):152-71. doi: 10.1002/cmdc.200600204. ChemMedChem. 2007. PMID: 17163561 Review.
-
Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs.Biochimie. 2005 Mar-Apr;87(3-4):393-402. doi: 10.1016/j.biochi.2004.09.025. Biochimie. 2005. PMID: 15781327 Review.
Cited by
-
Newly Designed Quinolinol Inhibitors Mitigate the Effects of Botulinum Neurotoxin A in Enzymatic, Cell-Based, and ex Vivo Assays.J Med Chem. 2017 Jan 12;60(1):338-348. doi: 10.1021/acs.jmedchem.6b01393. Epub 2017 Jan 3. J Med Chem. 2017. PMID: 27966961 Free PMC article.
-
Synthesis and evaluation of novel heterocyclic MMP inhibitors.Bioorg Med Chem Lett. 2007 Dec 15;17(24):6864-70. doi: 10.1016/j.bmcl.2007.10.020. Epub 2007 Oct 17. Bioorg Med Chem Lett. 2007. PMID: 18029173 Free PMC article.
-
From Zn to Mn: the study of novel manganese-binding groups in the search for new drugs against tuberculosis.Chem Biol Drug Des. 2011 Feb;77(2):117-23. doi: 10.1111/j.1747-0285.2010.01060.x. Chem Biol Drug Des. 2011. PMID: 21266015 Free PMC article.
-
Mechanistic insight into hydroxamate transfer reaction mimicking the inhibition of zinc-containing enzymes.Chem Sci. 2020 Aug 13;11(33):9017-9021. doi: 10.1039/d0sc02676j. Chem Sci. 2020. PMID: 34123156 Free PMC article.
-
Targeting metalloproteins by fragment-based lead discovery.Chem Biol Drug Des. 2011 Aug;78(2):211-23. doi: 10.1111/j.1747-0285.2011.01136.x. Epub 2011 Jun 16. Chem Biol Drug Des. 2011. PMID: 21564556 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous